Compared to other bacterial infections, Mycobacterium tuberculosis infection has fewer drug options, a longer course of treatment, and is difficult to treat, as well as the possibility of relapse. Improving one’s resistance and treating with anti-tuberculosis drugs early, regularly, throughout the course, in appropriate amounts, and in combination, can reduce relapse and drug resistance.